Cover Image
Market Research Report
Product code 
843037

Global C-Reactive Protein Test Market 2019-2023

Published: | TechNavio (Infiniti Research Ltd.) | 119 Pages | Delivery time: 1-2 business days

Price

Back to Top
Global C-Reactive Protein Test Market 2019-2023
Published: May 6, 2019
TechNavio (Infiniti Research Ltd.)
Content info: 119 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents

About this market

The rising prevalence of chronic diseases is one of the key factors expected to trigger the market growth during the forecast period. Chronic diseases including diabetes, stroke, cancer, arthritis, and others are responsible for seven out of 10 deaths among the people in the US. In addition, autoimmune diseases are a key health concern, further, driving the demand for CRP tests during the forecast period. The ability for diagnosing diseases increases significantly using CRP tests, while impacting the market growth positively during the forecast period. Technavio's analysts have predicted that the C-reactive protein test market will register a CAGR of over 1% by 2023.

Market Overview

Rising incidence of HIV in developing countries

The increasing incidence of HIV infections, especially in developing countries, posed a challenge to the economy. This has further necessitated the need for monitoring HIV disease activity through low-cost techniques such as CRP testing. HIV is a virus that enters the blood, and attacks and destroys the body's immune system, which results in the development of AIDS. Importance of evaluating the CRP level in HIV affected patients through hs-CRP assays has increased the demand for CRP testing and is expected to increase further during the forecast period, boosting the market growth.

Increasing data integrity issues

CRP testing data relies on recording observation, in which error may occur, resulting in manipulation and wrong information of results. This reduces the reliability of tests, which hinders market growth.

For the detailed list of factors that will drive and challenge the growth of the C-reactive protein test market during 2019-2023, view our report.

Competitive Landscape

The market appears to be moderately concentrated and with the presence of a few market players. Vendors are offering high-end innovative products that are using protein analysis to detect chronic diseases. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

Product Code: IRTNTR31207

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user
  • Comparison by end-user
  • Hospitals - Market size and forecast 2018-2023
  • Clinical laboratories - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • Danaher
  • F Hoffmann-La Roche Ltd
  • Merck KGaA
  • Thermo Fisher Scientific Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of vendor positioning

PART 15: EXPLORE TECHNAVIO

List of Exhibits

  • Exhibit 01: Global healthcare market
  • Exhibit 02: Segments of global healthcare market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2018
  • Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 09: Five forces analysis 2018
  • Exhibit 10: Five forces analysis 2023
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2018
  • Exhibit 17: End-user - Market share 2018-2023 (%)
  • Exhibit 18: Comparison by end-user
  • Exhibit 19: Hospitals - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 20: Hospitals - Year-over-year growth 2019-2023 (%)
  • Exhibit 21: Clinical laboratories - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 22: Clinical laboratories - Year-over-year growth 2019-2023 (%)
  • Exhibit 23: Others - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 24: Others - Year-over-year growth 2019-2023 (%)
  • Exhibit 25: Market opportunity by end-user
  • Exhibit 26: Customer landscape
  • Exhibit 27: Market share by geography 2018-2023 (%)
  • Exhibit 28: Geographic comparison
  • Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 30: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 32: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 34: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 36: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 37: Key leading countries
  • Exhibit 38: Market opportunity
  • Exhibit 39: Impact of drivers and challenges
  • Exhibit 40: Vendor landscape
  • Exhibit 41: Landscape disruption
  • Exhibit 42: Vendors covered
  • Exhibit 43: Vendor classification
  • Exhibit 44: Market positioning of vendors
  • Exhibit 45: Abbott - Vendor overview
  • Exhibit 46: Abbott - Business segments
  • Exhibit 47: Abbott - Organizational developments
  • Exhibit 48: Abbott - Geographic focus
  • Exhibit 49: Abbott - Segment focus
  • Exhibit 50: Abbott - Key offerings
  • Exhibit 51: Danaher - Vendor overview
  • Exhibit 52: Danaher - Business segments
  • Exhibit 53: Danaher - Organizational developments
  • Exhibit 54: Danaher - Geographic focus
  • Exhibit 55: Danaher - Segment focus
  • Exhibit 56: Danaher - Key offerings
  • Exhibit 57: F Hoffmann-La Roche Ltd - Vendor overview
  • Exhibit 58: F Hoffmann-La Roche Ltd - Product segments
  • Exhibit 59: F Hoffmann-La Roche Ltd - Organizational developments
  • Exhibit 60: F Hoffmann-La Roche Ltd - Geographic focus
  • Exhibit 61: F Hoffmann-La Roche Ltd - Segment focus
  • Exhibit 62: F Hoffmann-La Roche Ltd - Key offerings
  • Exhibit 63: Merck KGaA - Vendor overview
  • Exhibit 64: Merck KGaA - Business segments
  • Exhibit 65: Merck KGaA - Organizational developments
  • Exhibit 66: Merck KGaA - Geographic focus
  • Exhibit 67: Merck KGaA - Segment focus
  • Exhibit 68: Merck KGaA - Key offerings
  • Exhibit 69: Thermo Fisher Scientific Inc. - Vendor overview
  • Exhibit 70: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 71: Thermo Fisher Scientific Inc. - Organizational developments
  • Exhibit 72: Thermo Fisher Scientific Inc. - Geographic focus
  • Exhibit 73: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibit 74: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 75: Validation techniques employed for market sizing
  • Exhibit 76: Definition of vendor positioning